Beijing Chunlizhengda Medical Instruments saw the highest growth of 146% in patent filings and 143% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 146% and grants by 143%. GlobalData’s DataBook provides a comprehensive analysis of Beijing Chunlizhengda Medical Instruments’s patent filings and grants. Buy the databook here.
Beijing Chunlizhengda Medical Instruments has been focused on protecting inventions in China(CN) with 35 publications in Q1 2024
The China(CN) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The China(CN) patent Office are among the top ten patent offices where Beijing Chunlizhengda Medical Instruments is filings its patents. Among the top granted patent authorities, Beijing Chunlizhengda Medical Instruments has 100% of its grants in China(CN).
Johnson & Johnson could be the strongest competitor for Beijing Chunlizhengda Medical Instruments
In terms of grant share, Beijing Chunlizhengda Medical Instruments stands in seventh position among its competitors. Beijing Chunlizhengda Medical Instruments and Johnson & Johnson secured the top positions according to recent patent publication data.
Patents related to robotics and wearable tech lead Beijing Chunlizhengda Medical Instruments's portfolio
Beijing Chunlizhengda Medical Instruments has the highest number of patents in robotics followed by, wearable tech. For robotics, nearly 67% of patents were filed and no patents were granted in Q1 2024.
For comprehensive analysis of Beijing Chunlizhengda Medical Instruments's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.